azacitidine has been researched along with Cancer of Cervix in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (8.33) | 18.2507 |
2000's | 14 (38.89) | 29.6817 |
2010's | 18 (50.00) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Dong, H; He, X; Li, H; Wang, T; Yuan, Y; Zhang, D; Zhou, L | 1 |
Baguet, A; Demeret, C; Guenat, D; Jacquin, E; Morel, A; Mougin, C; Perrard, J; Prétet, JL | 1 |
Chen, GD; Fan, GY; Li, ZG; Qian, DY; Wu, YL; You, KL | 1 |
Cui, Y; Ding, M; Gao, Y; Li, X; Li, Y; Singh, N; Tian, R; Wu, X; Yang, Y | 1 |
Huang, ML; Lin, ZQ; Liu, LY; Lu, HW; Mo, SM; Yao, TT | 1 |
Liang, J; Lin, Z; Liu, L; Rao, Q; Xie, Q; Yao, T; Zheng, C | 1 |
Hsu, CL; Kuo, CC; Li, HJ; Lin, WC; Lin, YW; Yan, MD; Yu, PN | 1 |
Yang, WT; Zheng, PS | 1 |
Jin, R; Kim, H; Lee, DY; Renshu, L; Roh, MR; Yang, S; Yingji, S; Zhang, X; Zheng, Z | 1 |
Chu, TY; Ding, DC; Huang, RL; Lin, CJ; Liu, CJ; Liu, DW; Wang, KH; Weng, CF | 1 |
Sood, S; Srinivasan, R | 1 |
Kwok, TT; Tsang, TY; Yau, PL; Yeung, CL | 1 |
Chen, XW; Cheng, HY; Cheng, L; Liu, YD; Lou, G | 1 |
Brown, KD; Darst, RP; Delmas, AL; Dyer, LM; Hakam, A; Izumchenko, EG; Kladde, MP; Monroe, M; Pardo, CE; Riggs, BM; Siegel, EM | 1 |
Anant, S; Benbrook, DM; Lightfoot, S; Mills, WK; Natarajan, G; Queimado, L; Ramachandran, I; Ramalingam, S; Reis, A; Thavathiru, E; Zuna, R | 1 |
Bai, T; Kobayashi, A; Matsuoka, T; Sasaki, N; Tanaka, J; Tanaka, T; Tanizaki, Y; Toujima, S; Utsunomiya, H; Utsunomiya, T; Yamamoto, M; Yukawa, K | 1 |
Basu, PS; Mazumder-Indra, D; Mitra, S; Mondal, RK; Panda, CK; Roy, A; Roychoudhury, S | 1 |
Aoki, D; Banno, K; Kisu, I; Kobayashi, Y; Masuda, K; Nomura, H; Susumu, N; Tominaga, E; Tsuji, K; Ueki, A; Yamagami, W; Yanokura, M | 1 |
Calonne, E; Delbecque, K; Delvenne, P; Deplus, R; Ennaji, MM; Fuks, F; Guenin, S; Kridelka, F; Krusy, N; Lampe, X; Mouallif, M | 1 |
Caldas, AP; Campos, O; Cancella, AI; Dal Lago, L; DiLeone, LP; Monego, E; Pohlmann, P; Rivoire, W; Schwartsmann, G | 1 |
Chan, AW; Chan, MW; Chan, PK; Lee, TL; Lo, KW; To, KF; Tong, JH; Yu, MY | 1 |
Acuña, C; Chavez, A; Dueñas-Gonzalez, A; Lizano, M; Mariscal, I; Perez-Cardenas, E; Salazar, AM; Segura-Pacheco, B; Taja-Chayeb, L; Trejo-Becerril, C | 1 |
Chen, CL; Ip, SM; Liu, SS; Ng, TY; Ngan, HY; Wong, LC | 1 |
Brent, TP; Danam, RP; Harris, LC; Howell, SR | 1 |
Biesová, Z; Jakubicková, L; Kettmann, R; Pastorek, J; Pastoreková, S | 1 |
Bai, T; Tanaka, T; Umesaki, N; Yukawa, K | 1 |
Feng, Q; Geiss, G; Kiviat, N; Lieber, A; Rudolf, V; Sova, P; Strauss, R; Wood, T | 1 |
Barrera-Saldaña, HA; Bernard, HU; Calleja-Macias, IE; Cubie, HA; Cuschieri, K; Kalantari, M; Skomedal, H; Turan, T; Villa, LL | 1 |
Lu, Y; Ma, D; Meng, L; Wang, H; Wang, S; Wu, S; Wu, Y; Xi, L; Xu, G; Xu, Q; Zhao, Y; Zhou, J | 1 |
Bachmann, A; Rösl, F; Zawatzky, R | 1 |
Akiyoshi, J; Aoki, D; Banno, K; Fujii, T; Hirasawa, A; Iwata, T; Kawaguchi, M; Kobayashi, Y; Kuwabara, Y; Susumu, N; Tsukazaki, K; Yanokura, M | 1 |
Gao, YP; He, XH; Li, M; Wang, H; Wang, ZH; Zhang, YY | 1 |
Bernard, HU; Calleja-Macias, IE; Kalantari, M; Lambert, PF; Lee, D | 1 |
Blessing, JA; Manetta, A; Mann, WJ; Smith, DM | 1 |
Hashimoto, K; Kato, H; Nakamura, K; Sasaki, K; Tamura, H; Tsuyama, S | 1 |
Guastalla, JP; Renard, J; Roozendaal, KJ; Splinter, TA; Tumolo, S; Vermorken, JB | 1 |
2 trial(s) available for azacitidine and Cancer of Cervix
Article | Year |
---|---|
Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carcinoma, Squamous Cell; Cisplatin; Decitabine; Enzyme Inhibitors; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Survival Analysis; Uterine Cervical Neoplasms | 2002 |
A phase II study of fazarabine (NSC 281272) in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Carcinoma, Squamous Cell; Female; Humans; Middle Aged; Uterine Cervical Neoplasms | 1995 |
34 other study(ies) available for azacitidine and Cancer of Cervix
Article | Year |
---|---|
Foxo3a-Mediated DNMT3B Impedes Cervical Cancer Cell Proliferation and Migration Capacities through Suppressing PTEN Promoter Methylation.
Topics: Azacitidine; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Female; Humans; Promoter Regions, Genetic; PTEN Phosphohydrolase; Signal Transduction; Uterine Cervical Neoplasms | 2023 |
5azadC treatment upregulates miR-375 level and represses HPV16 E6 expression.
Topics: Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Viral; Human papillomavirus 16; Humans; MicroRNAs; Oncogene Proteins, Viral; Papillomavirus Infections; Repressor Proteins; Up-Regulation; Uterine Cervical Neoplasms | 2017 |
Down-regulation of p16 and MGMT promotes the anti-proliferative and pro-apoptotic effects of 5-Aza-dC and radiation on cervical cancer cells.
Topics: Apoptosis; Azacitidine; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p18; Decitabine; DNA Modification Methylases; DNA Repair Enzymes; Down-Regulation; Female; Humans; Tumor Suppressor Proteins; Uterine Cervical Neoplasms; X-Rays | 2017 |
Promoter hypermethylation of SOX11 promotes the progression of cervical cancer in vitro and in vivo.
Topics: Adult; Azacitidine; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; CpG Islands; Disease Progression; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Middle Aged; Promoter Regions, Genetic; SOXC Transcription Factors; Tumor Suppressor Proteins; Up-Regulation; Uterine Cervical Neoplasms | 2019 |
5-Aza-2'-deoxycytidine may influence the proliferation and apoptosis of cervical cancer cells via demethylation in a dose- and time-dependent manner.
Topics: Apoptosis; Apoptotic Protease-Activating Factor 1; Azacitidine; Cell Growth Processes; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2013 |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer.
Topics: Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Profiling; Gene Silencing; Humans; Microarray Analysis; MicroRNAs; Real-Time Polymerase Chain Reaction; Uterine Cervical Neoplasms | 2013 |
The role of Sp1 and EZH2 in the regulation of LMX1A in cervical cancer cells.
Topics: Azacitidine; Base Sequence; Binding Sites; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Gene Silencing; Histone Deacetylase Inhibitors; Histones; Humans; LIM-Homeodomain Proteins; Methylation; Molecular Sequence Data; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Transcription Factors; Uterine Cervical Neoplasms | 2013 |
Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.
Topics: Azacitidine; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cisplatin; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Humans; Kruppel-Like Factor 4; Kruppel-Like Transcription Factors; Promoter Regions, Genetic; Protein Biosynthesis; Transcription, Genetic; Tumor Suppressor Proteins; Uterine Cervical Neoplasms | 2014 |
Downregulation of glutathione peroxidase 3 is associated with lymph node metastasis and prognosis in cervical cancer.
Topics: Azacitidine; CpG Islands; Decitabine; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; HeLa Cells; Humans; Lymphatic Metastasis; Prognosis; Promoter Regions, Genetic; Uterine Cervical Neoplasms | 2014 |
Global methylation silencing of clustered proto-cadherin genes in cervical cancer: serving as diagnostic markers comparable to HPV.
Topics: Adult; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Cadherins; Cell Adhesion; Cell Line, Tumor; CpG Islands; Disease Progression; DNA Methylation; Female; Gene Silencing; Genetic Loci; Humans; Middle Aged; Multigene Family; Neoplasm Invasiveness; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Severity of Illness Index; Uterine Cervical Neoplasms | 2015 |
Alterations in gene promoter methylation and transcript expression induced by cisplatin in comparison to 5-Azacytidine in HeLa and SiHa cervical cancer cell lines.
Topics: Apoptosis; Azacitidine; Cell Proliferation; Cisplatin; CpG Islands; DNA Methylation; Female; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; India; Neoplasm Proteins; Promoter Regions, Genetic; Uterine Cervical Neoplasms | 2015 |
Human papillomavirus type 16 E6 suppresses microRNA-23b expression in human cervical cancer cells through DNA methylation of the host gene C9orf3.
Topics: Aminopeptidases; Apoptosis; Azacitidine; Blotting, Western; Cell Line, Tumor; Decitabine; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; HCT116 Cells; Human papillomavirus 16; Humans; MicroRNAs; Oncogene Proteins, Viral; Promoter Regions, Genetic; Proto-Oncogene Proteins c-met; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Uterine Cervical Neoplasms | 2017 |
DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Topics: Azacitidine; Cell Line, Tumor; CpG Islands; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; Female; Gene Expression Regulation, Neoplastic; Genetic Predisposition to Disease; HeLa Cells; Humans; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription Factors; Uterine Cervical Neoplasms | 2010 |
WIF1 is a frequent target for epigenetic silencing in squamous cell carcinoma of the cervix.
Topics: Adaptor Proteins, Signal Transducing; Azacitidine; Blotting, Western; Carcinoma, Squamous Cell; Cell Line; Cervix Uteri; CpG Islands; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoenzyme Techniques; Promoter Regions, Genetic; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uterine Cervical Neoplasms | 2011 |
Wnt inhibitory factor 1 induces apoptosis and inhibits cervical cancer growth, invasion and angiogenesis in vivo.
Topics: Adaptor Proteins, Signal Transducing; Animals; Apoptosis; Azacitidine; beta Catenin; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cervix Uteri; Decitabine; DNA Methylation; Down-Regulation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Neoplasm Invasiveness; Neovascularization, Pathologic; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Uterine Cervical Neoplasms; Wnt Proteins | 2012 |
Demethylation restores SN38 sensitivity in cells with acquired resistance to SN38 derived from human cervical squamous cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis Regulatory Proteins; Azacitidine; Calcium-Calmodulin-Dependent Protein Kinases; Camptothecin; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Dealkylation; Death-Associated Protein Kinases; Decitabine; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; Promoter Regions, Genetic; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Uterine Cervical Neoplasms | 2012 |
Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances.
Topics: Azacitidine; Cell Line, Tumor; Decitabine; DNA Methylation; Female; Gene Silencing; Humans; Immunohistochemistry; Intercellular Signaling Peptides and Proteins; Nerve Tissue Proteins; Precancerous Conditions; Prognosis; Promoter Regions, Genetic; Receptors, Immunologic; Roundabout Proteins; Uterine Cervical Neoplasms | 2012 |
Association of epigenetic inactivation of the WRN gene with anticancer drug sensitivity in cervical cancer cells.
Topics: Adenocarcinoma; Antineoplastic Agents; Azacitidine; Camptothecin; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; DNA Methylation; Epigenesis, Genetic; Exodeoxyribonucleases; Female; Gene Expression Regulation, Neoplastic; Humans; Irinotecan; RecQ Helicases; RNA, Small Interfering; Topoisomerase I Inhibitors; Uterine Cervical Neoplasms; Werner Syndrome Helicase | 2012 |
Aberrant promoter methylation and expression of UTF1 during cervical carcinogenesis.
Topics: Azacitidine; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cell Transformation, Neoplastic; Cervix Uteri; Cluster Analysis; Cytological Techniques; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Humans; Neoplasms, Glandular and Epithelial; Neoplastic Stem Cells; Nuclear Proteins; Octamer Transcription Factor-3; Ovarian Neoplasms; Promoter Regions, Genetic; Sequence Analysis, DNA; SOXB1 Transcription Factors; Trans-Activators; Uterine Cervical Neoplasms | 2012 |
Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21 in cervical cancers.
Topics: Adenocarcinoma; Adult; Aged; Azacitidine; Carcinoma, Squamous Cell; Chromosomes, Human, Pair 3; DNA Methylation; DNA Primers; DNA, Neoplasm; DNA, Viral; Enzyme Inhibitors; Female; Gene Silencing; Genes, Tumor Suppressor; Humans; Loss of Heterozygosity; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Staging; Papillomaviridae; Papillomavirus Infections; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Tumor Cells, Cultured; Tumor Suppressor Proteins; Tumor Virus Infections; Uterine Cervical Neoplasms | 2003 |
Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy.
Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Breast Neoplasms; Cell Cycle; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, Tumor Suppressor; Head and Neck Neoplasms; Humans; Hydralazine; Mice; Mice, Nude; Procainamide; Receptors, Estrogen; Receptors, Retinoic Acid; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
E-cadherin expression is silenced by DNA methylation in cervical cancer cell lines and tumours.
Topics: Antimetabolites, Antineoplastic; Azacitidine; Blotting, Western; Cadherins; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Female; Humans; Molecular Sequence Data; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.
Topics: Acetylation; Azacitidine; Cell Line, Transformed; Cell Line, Tumor; DNA Methylation; DNA-Binding Proteins; Female; Gene Expression Regulation, Enzymologic; Gene Silencing; HeLa Cells; Histones; Humans; Hydroxamic Acids; O(6)-Methylguanine-DNA Methyltransferase; Promoter Regions, Genetic; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Transcription, Genetic; Uterine Cervical Neoplasms | 2005 |
Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
Topics: Antigens, Neoplasm; Antimetabolites, Antineoplastic; Azacitidine; Biomarkers, Tumor; Carbonic Anhydrase IX; Carbonic Anhydrases; Carcinoma; Carcinoma, Renal Cell; Colonic Neoplasms; Decitabine; DNA Methylation; Female; Fibroblasts; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Isoenzymes; Kidney Neoplasms; Promoter Regions, Genetic; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2005 |
A novel mechanism for acquired cisplatin-resistance: suppressed translation of death-associated protein kinase mRNA is insensitive to 5-aza-2'-deoxycitidine and trichostatin in cisplatin-resistant cervical squamous cancer cells.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Azacitidine; Calcium-Calmodulin-Dependent Protein Kinases; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Death-Associated Protein Kinases; Decitabine; DNA Methylation; DNA Modification Methylases; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Promoter Regions, Genetic; Protein Biosynthesis; Protein Synthesis Inhibitors; RNA, Messenger; Uterine Cervical Neoplasms | 2006 |
Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis.
Topics: Azacitidine; Biomarkers, Tumor; Cell Line, Tumor; Cervix Uteri; CpG Islands; Decitabine; DNA Methylation; DNA, Neoplasm; Enzyme Inhibitors; Female; Gene Expression Regulation, Neoplastic; Genes, Neoplasm; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Microarray Analysis; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation; Uterine Cervical Neoplasms | 2006 |
Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression?
Topics: Azacitidine; Biomarkers, Tumor; Capsid Proteins; Cervix Uteri; Decitabine; DNA Methylation; DNA Modification Methylases; DNA-Binding Proteins; DNA, Viral; Enzyme Inhibitors; Female; HeLa Cells; Humans; Oncogene Proteins, Viral; Papillomaviridae; Proviruses; Regulatory Elements, Transcriptional; Uterine Cervical Neoplasms; Viral Proteins | 2006 |
Regulation of DNA methylation on the expression of the FHIT gene contributes to cervical carcinoma cell tumorigenesis.
Topics: Acid Anhydride Hydrolases; Apoptosis; Azacitidine; Cell Proliferation; Cells, Cultured; Decitabine; DNA Methylation; DNA Modification Methylases; Endothelium, Vascular; Enzyme Inhibitors; Female; Flow Cytometry; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Neoplasm Proteins; Reverse Transcriptase Polymerase Chain Reaction; Umbilical Veins; Uterine Cervical Neoplasms | 2006 |
Genetic redundancy in human cervical carcinoma cells: identification of cells with "normal" properties.
Topics: Animals; Azacitidine; Butyrates; Cardiovirus Infections; Decitabine; DNA Methylation; Encephalomyocarditis virus; Female; HeLa Cells; Histone Deacetylase Inhibitors; Human papillomavirus 18; Humans; Immunocompromised Host; Interferon Regulatory Factor-1; Interferon-beta; Interferon-Stimulated Gene Factor 3, gamma Subunit; Mice; Mice, Nude; Papillomavirus Infections; Tumor Necrosis Factor-alpha; Uterine Cervical Neoplasms | 2007 |
Epigenetic inactivation of the CHFR gene in cervical cancer contributes to sensitivity to taxanes.
Topics: Adenocarcinoma; Adenocarcinoma, Mucinous; Antimetabolites, Antineoplastic; Antineoplastic Agents; Azacitidine; Bridged-Ring Compounds; Carcinoma, Squamous Cell; Cell Cycle Proteins; DNA Methylation; DNA, Neoplasm; Drug Tolerance; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Neoplasm Proteins; Poly-ADP-Ribose Binding Proteins; Promoter Regions, Genetic; RNA, Small Interfering; Taxoids; Tumor Cells, Cultured; Ubiquitin-Protein Ligases; Uterine Cervical Neoplasms | 2007 |
[Relationship between RAR-beta gene expression defect and its methylation].
Topics: Azacitidine; Blotting, Western; Cell Line, Tumor; Cell Proliferation; DNA Methylation; Female; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Promoter Regions, Genetic; Receptors, Retinoic Acid; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Uterine Cervical Neoplasms | 2007 |
Effects of cellular differentiation, chromosomal integration and 5-aza-2'-deoxycytidine treatment on human papillomavirus-16 DNA methylation in cultured cell lines.
Topics: Azacitidine; Cell Differentiation; Decitabine; DNA Methylation; Epithelial Cells; Extrachromosomal Inheritance; Female; Human papillomavirus 16; Humans; Oncogene Proteins, Viral; Papillomavirus E7 Proteins; Repressor Proteins; Tumor Cells, Cultured; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Virus Integration | 2008 |
Different behaviors in the production and release of SCC antigen in squamous-cell carcinoma.
Topics: Animals; Antigens, Neoplasm; Azacitidine; Carcinoma, Squamous Cell; Cell Count; Cell Division; Female; Immunohistochemistry; Intracellular Fluid; Mice; Mice, Nude; Serpins; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 1991 |
5-aza-2'-deoxycytidine in advanced or recurrent cancer of the uterine cervix.
Topics: Adult; Aged; Antineoplastic Agents; Azacitidine; Decitabine; Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Uterine Cervical Neoplasms | 1991 |